000			02188 a2200553 4500
005			20250516021436.0
264		0	_c20110512
008			201105s 0 0 eng d
022			_a1365-2141
024	7		_a10.1111/j.1365-2141.2010.08533.x _2doi
040			_aNLM _beng _cNLM
100	1		_aHunsucker, Sally A
245	0	0	_aBlockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma. _h[electronic resource]
260			_bBritish journal of haematology _cMar 2011
300			_a579-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBH3 Interacting Domain Death Agonist Protein _xmetabolism
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aHumans
650	0	4	_aInterleukin-6 _xantagonists & inhibitors
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMultiple Myeloma _xmetabolism
650	0	4	_aNeoplasm Proteins _xmetabolism
650	0	4	_aPlasma Cells _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTumor Cells, Cultured
650	0	4	_abcl-2 Homologous Antagonist-Killer Protein _xmetabolism
650	0	4	_abcl-2-Associated X Protein _xmetabolism
700	1		_aMagarotto, Valeria
700	1		_aKuhn, Deborah J
700	1		_aKornblau, Steven M
700	1		_aWang, Michael
700	1		_aWeber, Donna M
700	1		_aThomas, Sheeba K
700	1		_aShah, Jatin J
700	1		_aVoorhees, Peter M
700	1		_aXie, Hong
700	1		_aCornfeld, Mark
700	1		_aNemeth, Jeffrey A
700	1		_aOrlowski, Robert Z
773	0		_tBritish journal of haematology _gvol. 152 _gno. 5 _gp. 579-92
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2010.08533.x _zAvailable from publisher's website
999			_c20523809 _d20523809